Controlled study on thymol + eugenol vaginal douche versus econazole in vaginal candidiasis and metronidazole in bacterial vaginosis

Abstract

Purpose of the study.

Bacterial vaginosis (BV) and vaginal candidiasis (VC) are usually managed with topical antibiotics. This study compared the efficacy of a thymol + eugenol vaginal douche (SD) (CAS nr. thymol: 89-83-8 and eugenol: 97-53-0), with econazole (CAS 27220-47-9) in VC and metronidazole (CAS 443-48-1) in BV, as suppository reference therapies. Thymol and eugenol are natural antibacterial and antimycotic active ingredients extracted from plants.

Methods:

A multicentre, parallel group, randomized study was performed, after stratification for diagnosis. Twenty-three Italian gynaecological units enrolled 459 patients (232 BV, 227 VC). The treatments applied were as follows: SD 1 douche/day (Saugella lavanda Attiva®) for 1 week, 1 metronidazole vaginal suppository/night for 1 week and 1 econazole vaginal suppository/night for 3 days. Clinical evaluations were performed before and 1 week after treatment.

Results:

A similar significant symptom reduction was observed with metronidazole and SD in BV and with econazole and SD in VC.

Conclusion:

SD was found to be an effective prescription drug in minor recurrent vaginal infectious episodes and its use can reduce the repeated exposure to antibiotics.

Key words

Bacterial vaginosis - Eugenol - Plant extracts - Thymol - Vaginal candidiasis - Vaginal douche

• References

• 1 Tepe B, Daferera D, Sokmen M, Polission M, Sokmen A. In vitro antimicrobial and antioxidant activities of the essential oils of various extract of thymus eigii M. Zohary et P.H. Davis. J Agric Food Chem. 2004; 52: 1132-7
• 2 Moleyar U. Narasimham P. Antibacterial activity of essential oil components. Int J Food Microbiol. 1992; 16: 337-2
• 3 Sato K, Krist S, Buchbauer G. Antimicrobial effect of trans-cinnamaldehyde, (-)-perillaldehyde, (-)-citronellal, citral, eugenol and carvacrol on airborne microbes using an airwasher. Biol Pharm Bull. 2006; 29: 2292-4
• 4 Braga PC. Thymol: antibacterial, antifungal and antioxidant activities. Giorn It Ost Gin. 2005; XXVII: 267-272
• 5 Pina-Vaz C, Rodrigues G, Pinto E, Costa-de-Oliveira S, Tavares C, Salgueiro L et al Antifungal activity of thymus oils and their major components. Eur Acad Dermatol Venereol. 2004; 18: 73-8
• 6 Braga PC, Alfieri M, Culici M, Dal Sasso M. Inhibitory activity of thymol against the formation of Candida albicans hyphae. Mycoses. 2007; 50: 502-6
• 7 Chami N, Bernis S, Chami F, Abounekhra A, Remmal A. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo . Oral Microbiol Immunol. 2005; 20: 106-11
• 8 Braga PC, Dal Sasso M, Culici M, Galestri L, Marceca MT, Guffanti EE. Antioxidant potential of thymol determined by chemiluminescence inhibition in human neutrophils and cell-free systems. Pharmacology. 2006; 76: 61-8
• 9 Braga PC, Dal Sasso M, Culici M, Bianchi T, Bordoni L, Marabini L. Anti-inflammatory activity of thymol: inhibitory effect on the release of human neutrophil elastase. Pharmacology. 2006; 77: 130-6
• 10 Didry N, Dubreuil L, Pinthas M. Antibacterial activity of thymol, carvacrol and cinnamaldehyde alone or in combination. Pharmazie. 1993; 48: 301-4
• 11 Dal Sasso M, Culici M, Alfieri M, Braga PC. Eugenol and thymol, alone and in combination, induce morphological alterations in the envelope of Candida albicans . Fitoterapia. 2007; 78: 396-400
• 12 Dal Sasso M, Culici M, Braga PC, Guffanti EE, Mucci M. Thymol: inhibitory activity on Escherichia coli and Staphylococcus aureus adhesion to human vaginal cells. J Essent Oil Res. 2006; 18: 455-61
• 13 Culici M, Capretti V, Dal Sasso M, Guffanti EE, Mucci M, Braga PC. Evaluation of thymol inhibition of Candida albicans adhesiveness to human vaginal cells. GIMMOC. 2005; IX: 107-14
• 14 Braga PC, Spallino A, Sturla C, Culici M, Dal Sasso M, Wang YY. Effects of thymol on the adhesiveness of Gardnerella vaginalis to human vaginal cells. GIMMOC. 2010; XIV: l-8
• 15 Braga PC, Culici M, Alfieri M, Dal Sasso M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int J Antimicrob Agents. 2008; 31: 472-7
• 16 Braga PC, Dal Sasso M, Culici M, Spallino A. Inhibitory activity of thymol on native and mature Gardnerella vaginalis biofilms: in vitro study. Arzneimittelforschung. 2010; 60 (11) 675-81
• 17 Griffin SG, Wyllie SG, Markham JL, Leach DN. The role of structure and molecular properties of terpenoids in determining their antimicrobial activity. Flavour Fragr J. 1999; 14: 322-32
• 18 Giordani R, Regli P, Kaloustian J, Mikail C, Abour L, Portugal H. Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris . Phytother Res. 2004; 18 (12) 990-5
• 19 Fukazawa Y, Kagaya A. Molecular bases of adhesion of Candida albicans. J Med Vet Mycol. 1997; 35 (2) 87-99
• 20 Hostetter MK. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Microbiol Rev. 1994; 7 (l) 29-42
• 21 Pendrak ML, Klotz SA. Adherence of Candida albicans to host cells. FEMS Microbiol Lett. 1995; 129: 103-13
• 22 Sobel JD, Muller G, Buckley HD. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun. 1984; 44 (3) 576-80
• 23 Demirezen S, Beksaç MS. Relationship between the morphology of Candida cells and vaginal discharge. New Microbiol. 2004; 27 (2) 173-6
• 24 Domer JE. Candida cell wall mannan: a polysaccharide with diverse immunologic properties. Crit Rev Microbiol. 1989; 17 (1) 33-51
• 25 Braga PC, Spallino A, Dal Sasso A, Sturla C, Culici M. Visual analysis of vaginal cell binding and retention of a gynecological douche. Min Ginecol. 2010; 62: 7-16